Home Stocks Stocks This Week: Mondelez, IDEXX Labs And Alexion Pharmaceuticals

Stocks This Week: Mondelez, IDEXX Labs And Alexion Pharmaceuticals

11 min read
0
96

<div _ngcontent-c16 innerhtml="

Success in cycles research is based upon the analysis of different types of cycles. The most basic cycle is the annual rhythm. This is the seasonal cycle that we hear much about in the business media. For example, the S&P is usually strong in the spring, makes a high in the summer, and tends to correct in September and October. The same patterns exist in the prices of individual stocks. However, the annual cycle is not the only one at work. In order to increase the probability of success, all other profitable cycles are isolated and are combined into a composite. Investors can best tilt the odds in their favor when both cycles agree.

Three stocks are showing a high likelihood of making runs over the next few weeks. Mondelez is poised to move higher by the end of this month. Over the last 17 years, the stock has traded higher from this date through to September 1 in over 70% of all cases, the third highest in the NASDAQ 100 for that time span. The dynamic weekly cycle rises through September, but I note that next month has not been a strong one for these shares. Mondelez has risen only 44% of the time in September. Technically, the stock is oversold on a daily and a monthly basis. Relative strength bottomed in May and has been rising for about 3 months, the minimum level that one would accept as signaling a trend change. The stock is likely to challenge $44 over the near term.

Chart 1

This cycle bottoms in the coming week.Cycles Research Investments LLC

Chart 2

Relative strength has been rising.Cycles Research Investments LLC

IDEXX Labs yields a cycle buy signal on August 22nd. Note that all of the seven buy signals have been profitable in the last year. Scanning the NASDAQ for seasonal cycles, IDEXX has been the single best performer from August 18th through September 30th, rising over 80% of the time in that time span over the last 27 years. The stock is overbought and thereby more risky than Mondelez, but there are no signs of weakness.

Chart 3

The IDEXX cycle points to higher prices.Cycles Research Investments LLC

Chart 4

Relative strength is strong, but this stock is very extended.Cycles Research Investments LLC

Over the past 22 years, Alexion Pharmaceuticals has been the fourth best performer from August 18th through the end of September, rising 73% of the time. The average price rise has been 11.2%, the second highest number on the NASDAQ. The weekly cycle bottoms on the 25th and does not peak until October. Six of the last seven buy signals in the past year have succeeded.

Chart 5

This cycle bottoms on August 25th.Cycles Research Investments LLC

Chart 6

This stock is oversold on a daily basis.Cycles Research Investments LLC

” readability=”39.746457867263″>

Success in cycles research is based upon the analysis of different types of cycles. The most basic cycle is the annual rhythm. This is the seasonal cycle that we hear much about in the business media. For example, the S&P is usually strong in the spring, makes a high in the summer, and tends to correct in September and October. The same patterns exist in the prices of individual stocks. However, the annual cycle is not the only one at work. In order to increase the probability of success, all other profitable cycles are isolated and are combined into a composite. Investors can best tilt the odds in their favor when both cycles agree.

Three stocks are showing a high likelihood of making runs over the next few weeks. Mondelez is poised to move higher by the end of this month. Over the last 17 years, the stock has traded higher from this date through to September 1 in over 70% of all cases, the third highest in the NASDAQ 100 for that time span. The dynamic weekly cycle rises through September, but I note that next month has not been a strong one for these shares. Mondelez has risen only 44% of the time in September. Technically, the stock is oversold on a daily and a monthly basis. Relative strength bottomed in May and has been rising for about 3 months, the minimum level that one would accept as signaling a trend change. The stock is likely to challenge $44 over the near term.

Chart 1

This cycle bottoms in the coming week.Cycles Research Investments LLC

Chart 2

Relative strength has been rising.Cycles Research Investments LLC

IDEXX Labs yields a cycle buy signal on August 22nd. Note that all of the seven buy signals have been profitable in the last year. Scanning the NASDAQ for seasonal cycles, IDEXX has been the single best performer from August 18th through September 30th, rising over 80% of the time in that time span over the last 27 years. The stock is overbought and thereby more risky than Mondelez, but there are no signs of weakness.

Chart 3

The IDEXX cycle points to higher prices.Cycles Research Investments LLC

Chart 4

Relative strength is strong, but this stock is very extended.Cycles Research Investments LLC

Over the past 22 years, Alexion Pharmaceuticals has been the fourth best performer from August 18th through the end of September, rising 73% of the time. The average price rise has been 11.2%, the second highest number on the NASDAQ. The weekly cycle bottoms on the 25th and does not peak until October. Six of the last seven buy signals in the past year have succeeded.

Chart 5

This cycle bottoms on August 25th.Cycles Research Investments LLC

Chart 6

This stock is oversold on a daily basis.Cycles Research Investments LLC

Let’s block ads! (Why?)


Source link